The API sector weakened, and the East Asian pharmaceutical industry fell to a standstill, while Shengnuo Biotech, Sunflower, Rundu Co., Ltd., Minova, Xinjiangjiang, and Xinhua Pharmaceuticals followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.